Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas

Journal of Hepatology

Volumn 43, Issue 6, 2005, Pages 1013-1020

  Jinushi, Masahisa ^a   Takehara, Tetsuo ^a   Tatsumi, Tomohide ^a   Hiramatsu, Naoki ^a   Sakamori, Ryotaro ^a   Yamaguchi, Shinjiro ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

DC; HCC; Liver; MIA; NK, MIC; NKG2D; Tumor

Indexed keywords

LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 RELATED CHAIN A; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LIVER CELL CARCINOMA; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DENDRITIC CELLS; FEMALE; HEPATITIS, CHRONIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC;

EID: 27744566433     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.05.026     Document Type: Article

References (26)

1. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 62 2003 1907 1917
2. I.N. Crispe Hepatic T cells and liver tolerance Nat Rev Immunol 3 2002 51 62
3. M.J. Smyth, Y. Hayakawa, K. Takeda, and H. Yagita New aspects of natural killer cell surveillance and therapy of cancer Nat Rev Cancer 2 2002 850 861
4. C.A. Biron, K.B. Nguyen, G.C. Pien, L.P. Cousens, and P. Salazar-Mather Natural killer cells in antiviral defence: function and regulation by innate cytokines Ann Rev Immunol 17 1999 189 220
5. A. Moretta Natural killer cells and dendritic cells: rendezvous in abused tissues Nat Rev Immunol. 2 2003 957 967
6. M.A. Degli-Esposti, and M.J. Smyth Close encounters of different kinds: Dendritic cells and NK cells take centre stage Nat Rev Immunol. 5 2005 112 124
7. A. Cerwenka, and L.L. Lanier Natural killer cells, viruses and cancer Nat Rev Immunol 1 2001 41 49
8. D.H. Raulet Roles of the NKG2D immunoreceptor and its ligands Nat Rev Immunol 3 2003 781 790
9. S. Bauer, V. Groh, J. Wu, A. Steinle, J.H. Phillips, and L.L. Lanier Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA Science 285 1999 727 729
10. V. Groh, R. Rhinehart, H. Secrist, S. Bauer, K.H. Grabstein, and T. Spies Broad tumor-associated expression and recognition by tumor-derived γδT cells of MICA and MICB Proc Natl Acad Sci USA 96 1999 6879 6884
11. J.D. Wu, L.M. Higgins, A. Steinle, D. Cosman, K. Haugk, and S.R. Plymate Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer J Clin Invest 114 2004 560 568
12. M. Jinushi, T. Takehara, T. Tatsumi, T. Kanto, V. Groh, and T. Spies Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid Int J Cancer. 104 2003 354 361
13. V. Groh, J. Wu, C. Yee, and T. Spies Tumor-derived soluble MIC ligands impair expression of NKG2D and T cell activation Nature 419 2002 734 738
14. H.R. Salih, H.G. Rammensee, and A. Steinle Down-regulation of MICA on human tumors by proteolytic shedding J Immunol 169 2002 4098 4102
15. E.S. Doubrovina, M.M. Doubrovin, E. Vider, R.B. Sisson, R.J. O'Reilly, and B. Dupon Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma J Immunol 171 2003 6891 6899
16. H.R. Salih, H. Antropius, F. Gieseke, S.Z. Lutz, L. Kanz, and H.G. Rammensee Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia Blood 102 2003 1389 1396
17. V. Groh, A. Bruhl, H. El-Gabalawy, J.L. Nelson, and T. Spies Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis Proc Natl Acad Sci USA 100 2003 9452 9457
18. M. Kudo, H. Chung, S. Haji, Y. Osaki, H. Oka, T. Seki, H. Kasugai, Y. Sasaki, and T. Matsunaga Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score Hepatology 40 2004 1396 1405
19. J.E. Gumperz, S. Miyake, T. Yamamura, and M.B. Brenner Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining J Exp Med 195 2002 625 636
20. M. Jinushi, T. Takehara, T. Kanto, T. Tatsumi, V. Groh, and T. Spies Critical role of MHC class I-related chain A and B expression on IFNα-stimulated dendritic cells in NK cell activation: Impairment in chronic hepatitis C infection J Immunol 170 2003 1249 1256
21. M. Jinushi, T. Takehara, T. Tatsumi, T. Kanto, V. Groh, and T. Spies Autocrine/Paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection J Immnunol 171 2003 5423 5429
22. LOW targets prime dendritic cells to induce protective CD8 T cell responses Immunity 19 2003 561 569
23. R.B. Mailliard, Y.I. Son, R. Redlinger, P.T. Coates, A. Giermasz, and P.A. Morel Dendritic cells mediate NK cell help for Th1 and CTL responses; Two signal requirement for induction of NK cell helper function J Immunol 171 2003 2366 2372
24. M. Jinushi, T. Takehara, T. Tatsumi, T. Kanto, T. Miyagi, and T. Suzuki The negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to the altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection J Immunol 173 2004 6072 6081
25. R. Castriconi, C. Cantoni, M. Della-Chiesa, M. Vitale, E. Marcenaro, and R. Conte Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells Proc Natl Acad Sci USA 100 2003 4120 4125
26. P. Bedossa, E. Peltier, B. Terris, D. Franco, and T. Poynard Transforming growth factor-beta 1 and TGF-beta 1 receptors in normal, cirrhotic and neoplastic human livers Hepatology 21 1995 760 766